Kansas · 2025-2026 Regular Session · Bill

SB 212: Enacting the prescription drug cost and affordability review act to establish the prescription drug pricing board and prescription drug affordability stakeholder council to review the cost of prescription medications and establish upper payment limits for certain prescription drugs.

Did not advance Last action April 10, 2026: Died in Committee

Plain-language summary

SB 212 is a bill introduced in the Kansas Senate on February 5, 2025. According to its official title, it concerns: Enacting the prescription drug cost and affordability review act to establish the prescription drug pricing board and prescription drug affordability stakeholder council to review the cost of prescription medications and establish upper payment limits for certain prescription drugs. Primary sponsor: Dinah Sykes (Democratic). Most recent recorded action (April 10, 2026): Died in Committee.

Sponsors

Primary sponsor: Dinah Sykes (Democratic).